GRAIL, Inc. (GRAL)
Nasdaq: GRAL · Services-Medical Laboratories · Menlo Park, CA · filing with the SEC since 2017
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Jan 1, 2023 | Dec 31, 2022 |
| Report filed | Mar 12, 2026 | Mar 5, 2025 | · | · | · |
| Revenue | 147,172 | 125,595 | 93,105 | 55,550 | · |
| For lenders | |||||
| Provision for credit losses | 332 | 0 | 0 | · | · |
| Research and development | 195,794 | 322,380 | 338,745 | 329,576 | · |
| Sales and marketing | 116,693 | 153,958 | 162,292 | 122,328 | · |
| General and administrative | 159,103 | 213,862 | 200,268 | 174,108 | · |
| Total costs and expenses | 709,335 | 2,314,753 | 1,608,487 | 5,498,440 | · |
| Operating income | -562,163 | -2,189,158 | -1,515,382 | -5,442,890 | · |
| Interest and investment income | 28,652 | 26,733 | 7,954 | 1,740 | · |
| Other income (expense), net | -993 | 64 | -208 | -238 | · |
| Total non-operating income (expense) | 27,659 | 26,797 | 7,746 | 1,502 | · |
| Income before income taxes | -534,504 | -2,162,361 | -1,507,636 | -5,441,388 | · |
| Income tax expense | -126,153 | -135,356 | -41,951 | -42,290 | · |
| Net income | -408,351 | -2,027,005 | -1,465,685 | -5,399,098 | · |
| Earnings per share, basic | -11.11 | -63.54 | -47.21 | -173.89 | · |
| Earnings per share, diluted | -11.11 | -63.54 | -47.21 | -173.89 | · |
| Weighted average shares, basic | 36,753,751 | 31,901,259 | 31,049,148 | 31,049,148 | · |
| Weighted average shares, diluted | 36,753,751 | 31,901,259 | 31,049,148 | 31,049,148 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxProvision for credit losses set aside for loans that may not be repaid
us-gaap:ProvisionForLoanLossesExpensedResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding